Prediction of Patient Deterioration Using Machine Learning
NCT ID: NCT05045742
Last Updated: 2021-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2021-03-20
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of 30-Day Readmission Using Machine Learning
NCT04849312
Prediction of Expected Length of Hospital Stay Using Machine Learning
NCT04784351
Early Warning System for Clinical Deterioration on General Hospital Wards
NCT01280942
Machine Learning-based Early Clinical Warning of High-risk Patients
NCT05410171
Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes
NCT01692847
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training
A subset of patients that are used to train the machine learning algorithm.
Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2
We will retrospectively compare the alarms produced from traditional vital sign alarms (thresholds set by clinicians) versus the BioVitals Index vs the National Early Warning Score 2
Validation
A subset of patients that are "held back" and used to validate the algorithm's accuracy.
Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2
We will retrospectively compare the alarms produced from traditional vital sign alarms (thresholds set by clinicians) versus the BioVitals Index vs the National Early Warning Score 2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2
We will retrospectively compare the alarms produced from traditional vital sign alarms (thresholds set by clinicians) versus the BioVitals Index vs the National Early Warning Score 2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biofourmis Inc.
INDUSTRY
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Levine
Attending Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Levine, MD MPH MA
Role: PRINCIPAL_INVESTIGATOR
Associate Physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brigham and Women's Hospital
Boston, Massachusetts, United States
Brigham and Women's Faulkner Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017P002583d
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.